Ji Xing Pharmaceuticals

Acquisition, funding and merger involving Ji Xing Pharmaceuticals.

• Ji Xing Pharmaceuticals has just announced a $162 Million fundraising (posted on January 15 2024).

View the org chart displaying its 18 main executives

Most searched biographies at Ji Xing Pharmaceuticals

• Sandy Mou, Chief Executive Officer and Executive Director
• Peter Fong, Director
• Roderick Wong, Chairman of the Board

Create your alert
to follow the executive moves at Ji Xing Pharmaceuticals.

Ji Xing Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Ji Xing Pharmaceuticals

Social media about Ji Xing Pharmaceuticals

• Ji Xing Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Ji Xing Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including John Jiang

Call Ji Xing Pharmaceuticals at +86 218...

View the org chart

Register to receive your alert

Report an error